Sandra Carson - 08 Jun 2021 Form 4 Insider Report for AGILE THERAPEUTICS INC

Role
Director
Signature
/s/ Geoffrey P. Gilmore, as Attorney-in Fact
Issuer symbol
N/A
Transactions as of
08 Jun 2021
Net transactions value
$0
Form type
4
Filing time
11 Jun 2021, 17:55:12 UTC
Next filing
10 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGRX Common Stock Award $0 +24,510 +92% $0.000000 51,296 08 Jun 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGRX Employee Stock Option (Right to Buy) Award $0 +29,905 $0.000000 29,905 08 Jun 2021 Common Stock 29,905 $1.53 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares represent restricted stock units that were granted on June 8, 2021, which will vest and be settled in common stock on June 8, 2022, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date and provided that the Reporting Person attends at least 75% of the board meetings held during the year of board service.
F2 The option was granted on June 8, 2021 and vests in full on June 8, 2022, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date and provided that the Reporting Person attends at least 75% of the board meetings held during the year of board service.